These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16423165)

  • 1. Increased risk of extrapyramidal side-effect treatment associated with atypical antipsychotic polytherapy.
    Carnahan RM; Lund BC; Perry PJ; Chrischilles EA
    Acta Psychiatr Scand; 2006 Feb; 113(2):135-41. PubMed ID: 16423165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing atypical antipsychotic treatment strategies in the elderly.
    Katz IR
    J Am Geriatr Soc; 2004 Dec; 52(12 Suppl):S272-7. PubMed ID: 15541168
    [No Abstract]   [Full Text] [Related]  

  • 3. Tardive dyskinesia in older patients.
    Jeste DV
    J Clin Psychiatry; 2000; 61 Suppl 4():27-32. PubMed ID: 10739328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO].
    István S; Agoston T; Tamás T; Zoltán J
    Neuropsychopharmacol Hung; 2007 Oct; 9(3):115-24. PubMed ID: 18399029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lewy body dementia: the litmus test for neuroleptic sensitivity and extrapyramidal symptoms.
    Baskys A
    J Clin Psychiatry; 2004; 65 Suppl 11():16-22. PubMed ID: 15264967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of EPS and tardive dyskinesia in clinical trials. Collaborative Working Group on Clinical Trial Evaluations.
    J Clin Psychiatry; 1998; 59 Suppl 12():23-7. PubMed ID: 9766616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of acute extrapyramidal signs and symptoms in patients treated with clozapine, risperidone, and conventional antipsychotics.
    Miller CH; Mohr F; Umbricht D; Woerner M; Fleischhacker WW; Lieberman JA
    J Clin Psychiatry; 1998 Feb; 59(2):69-75. PubMed ID: 9501888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic exposure and type 2 diabetes among patients with schizophrenia: a matched case-control study of California Medicaid claims.
    Lambert BL; Chou CH; Chang KY; Tafesse E; Carson W
    Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):417-25. PubMed ID: 15786516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clozapine-related extrapyramidal side effects: a case report.
    Gallo M; Squarcione C; Bersani FS; Minichino A; Fojanesi M; Biondi M
    Riv Psichiatr; 2017; 52(4):172-173. PubMed ID: 28845867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics.
    Finkel S; Kozma C; Long S; Greenspan A; Mahmoud R; Baser O; Engelhart L
    Int Psychogeriatr; 2005 Dec; 17(4):617-29. PubMed ID: 16202186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extrapyramidal side effects, tardive dyskinesia, and the concept of atypicality.
    Glazer WM
    J Clin Psychiatry; 2000; 61 Suppl 3():16-21. PubMed ID: 10724129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 6-month randomized open-label comparison of continuation of oral atypical antipsychotic therapy or switch to long acting injectable risperidone in patients with bipolar disorder.
    Yatham LN; Fallu A; Binder CE
    Acta Psychiatr Scand Suppl; 2007; (434):50-6. PubMed ID: 17688463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective prescribing of atypical antipsychotics.
    Breekveldt-Postma NS; Schillevoort I; Nolen WA; Veraart CP; Herings RM
    Pharmacoepidemiol Drug Saf; 2005 Jan; 14(1):25-30. PubMed ID: 15508132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiovascular risk of haloperidol vs. atypical anti-psychotic drugs in schizophrenia treatment].
    Dobrin I; Dobrin RP; Chele G; Stefănescu C; Knieling A; Chiriţă R
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(3):658-61. PubMed ID: 21243790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Movement Disorders in Children and Adolescents Receiving Antipsychotic Pharmacotherapy: A Population-Based Study.
    Biscontri RG; Jha S; Collins DM; Bugden S; Katz LY; Alessi-Severini S
    J Child Adolesc Psychopharmacol; 2017 Dec; 27(10):892-896. PubMed ID: 29091743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical antipsychotics and new onset diabetes mellitus. An overview of the literature.
    Cohen D
    Pharmacopsychiatry; 2004 Jan; 37(1):1-11. PubMed ID: 14750042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective cohort study of diabetes mellitus and antipsychotic treatment in a geriatric population in the United States.
    Feldman PD; Hay LK; Deberdt W; Kennedy JS; Hutchins DS; Hay DP; Hardy TA; Hoffmann VP; Hornbuckle K; Breier A
    J Am Med Dir Assoc; 2004; 5(1):38-46. PubMed ID: 14706127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of incidence rates of cerebrovascular accidents and transient ischaemic attacks in observational cohort studies of patients prescribed risperidone, quetiapine or olanzapine in general practice in England including patients with dementia.
    Layton D; Harris S; Wilton LV; Shakir SA
    J Psychopharmacol; 2005 Sep; 19(5):473-82. PubMed ID: 16166184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of neuroleptic-induced extrapyramidal syndromes under long-term neuroleptic treatment.
    Modestin J; Wehrli MV; Stephan PL; Agarwalla P
    Schizophr Res; 2008 Mar; 100(1-3):97-107. PubMed ID: 18055180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The scourge of EPS: have atypical antipsychotics solved the problem?
    J Clin Psychiatry; 2000 Dec; 61(12):955-62. PubMed ID: 11206607
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.